News and Trends 28 Feb 2017
It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?
…genes to the patient using viral vectors. Still in a very early phase, the company recently partnered with Oxford BioMedica to access its lentiviral vector technology. Mucopolysaccharidosis type III (MPS…